Sahin, T.K.; Akyildiz, A.; Dogan, O.T.; Kavgaci, G.; Guven, D.C.; Aksoy, S.
Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine. Pharmaceuticals 2024, 17, 824.
https://doi.org/10.3390/ph17070824
AMA Style
Sahin TK, Akyildiz A, Dogan OT, Kavgaci G, Guven DC, Aksoy S.
Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine. Pharmaceuticals. 2024; 17(7):824.
https://doi.org/10.3390/ph17070824
Chicago/Turabian Style
Sahin, Taha Koray, Arif Akyildiz, Osman Talha Dogan, Gozde Kavgaci, Deniz Can Guven, and Sercan Aksoy.
2024. "Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine" Pharmaceuticals 17, no. 7: 824.
https://doi.org/10.3390/ph17070824
APA Style
Sahin, T. K., Akyildiz, A., Dogan, O. T., Kavgaci, G., Guven, D. C., & Aksoy, S.
(2024). Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine. Pharmaceuticals, 17(7), 824.
https://doi.org/10.3390/ph17070824
